ML20217B866
| ML20217B866 | |
| Person / Time | |
|---|---|
| Issue date: | 08/25/1989 |
| From: | Harold Denton NRC OFFICE OF GOVERNMENTAL & PUBLIC AFFAIRS (GPA) |
| To: | Beckjord E NRC OFFICE OF NUCLEAR REGULATORY RESEARCH (RES) |
| Shared Package | |
| ML20217B758 | List: |
| References | |
| FOIA-98-86, RULE-PRM-35-7 NUDOCS 9804230144 | |
| Download: ML20217B866 (1) | |
Text
{{#Wiki_filter:o o 4*JL,8' UNITED STATES $8 NUCLEAR REGULATORY COMMISSION a &;$i? \\, /,I WASHINGTON,0, c. 20555 y a n,m y v g-y b hA' MEMORANDUM FOR: Eric S. Beckjord, Director Office of Nuc ear Regulator esearch / A FROM: paroldR. recto + 1 i Office of vernmental d Public Affairs
SUBJECT:
FINAL CONCURRENCE ON { We have reviewed and concur in the final rulemaking package in response to the petition for rulemaking to add Palladium-103 as a sealed source in seeds to the list of brachytherapy sources in 10 CFR 35.400. We appreciated the opportunity to work with your staff on this project since its 'veption. A/a 9eo4230144 9eo407 PDR FOIA THOMPSON 98-86 PDR 1
' sly; c.';.".' ' ' e,, * ' t,
- t. (lQ Cf6 ~
',y^qyy;9::t:y..e y: = - c~ g y, @ lY q / {. 2. In 5 35.400, paragra;h'(g) is WM to read as follows: f' met sp .w s g,y I 35.400 Use of sources for brachytherapy. Q$. W' (g) Palladitn-103 as a sealed source in seeds for interstitial treatrent Yrij h,h. of Cancer. rs" W 4,F F,0 Dated at Ibckv111e, Maryland, this day of , 1989. r; d. 4'. Ibr the Nuclear Regulatory hinnlan. r> 1 s p James M. Taylor, Acting Dce:utive Director for Operations. t i e b f,C l b CblM C IPES GPA AD4 IIX) +jj RDarnero 10anton 1ar abrry JTaylor / /89 / /89 f////89 / /89 / /89 g \\.0 017: RuymA k%:S ~ e }WE: ATse JI4.lford M is ,ord f IATE: h89 8/l[/89 8/j[/89 8/ /89 8/jf/89 89 8 09 [ Us OITICIAL RDONO CDFt i i 'e I.. t., 7 =}}